Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity

Journal of Hepatology

Volumn 54, Issue 6, 2011, Pages 1244-1249

  Fracanzani, Anna Ludovica ^a   Valenti, Luca ^a   Bugianesi, Elisabetta ^b   Vanni, Ester ^b   Grieco, Antonio ^c   Miele, Luca ^c   Consonni, Dario ^d   Fatta, Erika ^a   Lombardi, Rosa ^a   Marchesini, Giulio ^e   Fargion, Silvia ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Abdominal obesity; Glucose metabolism; NAFLD; NASH; Waist circumference

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; HYPERTENSION; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSITY; ADULT; ALANINE TRANSAMINASE; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPIDS; LIVER CIRRHOSIS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, ABDOMINAL; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 79956117037     PISSN: 01688278     EISSN: 01688278     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.09.037     Document Type: Article

References (41)

1. A.D. Karelis, D.H. St-Pierre, F. Conus, R. Rabasa-Lhoret, and E.T. Poehlman Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 89 2004 2569 2575 (Pubitemid 38766333)
2. L.A. Adams, O.R. Waters, M.W. Knuiman, R.R. Elliott, and J.K. Olynyk NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study Am J Gastroenterol 104 2009 861 867
3. M. Malaguarnera, M. Di Rosa, F. Nicoletti, and L. Malaguarnera Molecular mechanisms involved in NAFLD progression J Mol Med 87 2009 679 695
4. O. Cheung, A. Kapoor, P. Puri, S. Sistrun, V.A. Luketic, and C.C. Sargeant The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome Hepatology 46 2007 1091 1100 (Pubitemid 350144773)
5. T. Wasada, T. Kasahara, J. Wada, S. Jimba, R. Fujimaki, and T. Nakagami Hepatic steatosis rather than visceral adiposity is more closely associated with insulin resistance in the early stage of obesity Metabolism 57 2008 980 985 (Pubitemid 351814691)
6. H.J. Kim, H.J. Kim, K.E. Lee, D.J. Kim, S.K. Kim, and C.W. Ahn Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults Arch Intern Med 164 2004 2169 2175
7. S.A. Lear, K.H. Humphries, S. Kohli, and C.L. Birmingham The use of BMI and waist circumference as surrogates of body fat differs by ethnicity Obesity 15 2007 2817 2824
8. A. Bosy-Westphal, C.A. Booke, T. Blöcker, E. Kossel, K. Goele, and W. Later Measurement site for waist circumference affects its accuracy as an index of visceral and abdominal subcutaneous fat in a Caucasian population J Nutr 140 2010 954 961
9. F. Lirussi, N. Vitturi, L. Azzalini, S. Orando, R. Orlando, and M. Plebani Perihepatic adipose tissue thickness: a new non-invasive marker of NAFLD? J Gastrointestin Liver Dis 18 2009 61 66
10. S. Guldiken, N. Tuncbilek, O.O. Okten, E. Arikan, and A. Tugrul Visceral fat thickness determined using ultrasonography is associated with anthropometric and clinical parameters of metabolic syndrome Int J Clin Pract 60 2006 1576 1581 (Pubitemid 44742154)
11. A.L. Fracanzani, L. Valenti, E. Bugianesi, M. Andreoletti, A. Colli, and E. Vanni Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 48 2008 792 798
12. K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, and K.A. Donato Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity Circulation 120 2009 1640 1645
13. S.M. Haffner, H. Miettinen, and M.P. Stern The homeostasis model in the San Antonio heart study Diabetes Care 20 1997 1087 1092 (Pubitemid 27274268)
14. E.M. Brunt, C.G. Janney, A.M. Di Bisceglie, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474 (Pubitemid 29420675)
15. D.E. Kleiner, E.M. Brunt, M. Van Natta, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321 (Pubitemid 40770284)
16. K.G. Alberti, P. Zimmet, and J. Shaw International diabetes federation: a consensus on Type 2 diabetes prevention Diabet Med. 24 2007 451 463 (Pubitemid 46669328)
17. StataCorp. Stata: Release 11. Statistical Software: College Station, TX: StataCorp LP, 2009.
18. J. Westerbacka, M. Kolak, T. Kiviluoto, P. Arkkila, J. Sirén, and A. Hamsten Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects Diabetes 56 2007 2759 2765 (Pubitemid 350044919)
19. A. Rubio, E. Guruceaga, M. Vazquez-Chantada, J. Sandoval, L.A. Martinez-Cruz, and V. Segura Identification of a gene-pathway associated with non-alcoholic steatohepatitis J Hepatol 46 2007 708 718 (Pubitemid 46431167)
20. L. Valenti, R. Rametta, P. Dongiovanni, M. Maggioni, A.L. Fracanzani, and M. Zappa Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis Diabetes 57 2008 1355 1362
21. P. Dongiovanni, L. Valenti, R. Rametta, A.K. Daly, V. Nobili, and E. Mozzi Genetic variants regulating insulin receptor signaling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease Gut 59 2010 267 273
22. L. Valenti, A. Al-Serri, A.K. Daly, E. Galmozzi, R. Rametta, and P. Dongiovanni Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217
23. K.F. Petersen, S. Dufour, A. Hariri, C. Nelson-Williams, J.N. Foo, and X.M. Zhang Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease N Engl J Med 362 2010 1082 1089
24. M. Gus, F.T. Cichelero, C.M. Moreira, G.F. Escobar, L.B. Moreira, and M.F. Wiehe Waist circumference cut-off values to predict the incidence of hypertension: an estimation from a Brazilian population-based cohort Nutr Metab Cardiovasc Dis 19 2009 15 19
25. R. Rocha, H.P. Cotrim, F.M. Carvalho, A.C. Siqueira, H. Braga, and L.A. Freitas Body mass index and waist circumference in non-alcoholic fatty liver disease J Hum Nutr Diet 18 2005 365 370 (Pubitemid 41387905)
26. I.N. Guha, J. Parkes, P.R. Roderick, S. Harris, and W.M. Rosenberg Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease Gut 55 2006 1650 1660 (Pubitemid 44629217)
27. I.N. Guha, J. Parkes, P. Roderick, D. Chattopadhyay, R. Cross, and S. Harris Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers Hepatology 47 2008 455 460 (Pubitemid 351280713)
28. L.A. Adams, and P. Angulo Role of liver biopsy and serum markers of liver fibrosis in non-alcoholic fatty liver disease Clin Liver Dis 11 2007 25 35 (Review) (Pubitemid 46829969)
29. P. Angulo, J.M. Hui, G. Marchesini, E. Bugianesi, J. George, and G.C. Farrell The NAFLD fibrosis score: a non invasive system that identified liver fibrosis in patients with NAFLD Hepatology 45 2007 846 854 (Pubitemid 46631552)
30. M. Stepanova, R. Aquino, A. Alsheddi, R. Gupta, Y. Fang, and Z. Younossi Clinical predictors of fibrosis in patients with chronic liver disease Aliment Pharmacol Ther 31 2010 1085 1094
31. G.C. Farrell The liver and the waistline: Fifty years of growth J Gastroenterol Hepatol 24 2009 S105 S118
32. M. Manco, G. Bedogni, M. Marcellini, R. Devito, P. Ciampalini, and M.R. Sartorelli Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis Gut 57 2008 1283 1287
33. V. Nobili, A. Alisi, A. Vania, C. Tiribelli, A. Pietrobattista, and G. Bedogni The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease BMC Med 1 2009 7 21
34. C. Carter-Kent, L.M. Yerian, E.M. Brunt, P. Angulo, R. Kohli, and S.C. Ling Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study Hepatology 50 2009 1113 1120
35. P. Mathurin, A. Hollebecque, L. Arnalsteen, D. Buob, E. Leteurtre, and R. Caiazzo Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease Gastroenterology 137 2009 532 540
36. A. Gastaldelli, S.A. Harrison, R. Belfort-Aguilar, L.J. Hardies, B. Balas, and S. Schenker Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis Hepatology 50 2009 1087 1093
37. M. Konishi, S. Sugiyama, K. Sugamura, T. Nozaki, K. Ohba, and J. Matsubara Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease Atherosclerosis 209 2010 573 578
38. J.P. Després, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, and E. Larose Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk Arterioscler Thromb Vasc Biol 28 2008 1039 1049
39. K. Das, K. Das, P.S. Mukherjee, A. Ghosh, S. Ghosh, and A.R. Mridha Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease Hepatology 51 2010 1593 1602
40. L. Valenti, A.L. Fracanzani, E. Bugianesi, P. Dongiovanni, E. Galmozzi, and E. Vanni HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease Gastroenterology 138 2010 905 912
41. J.E. Nelson, R. Bhattacharya, K.D. Lindor, N. Chalasani, S. Raaka, and E.J. Heathcote E C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis Hepatology 46 2007 723 729 (Pubitemid 47436118)